Brokerages Set Omada Health, Inc. (NASDAQ:OMDA) Target Price at $22.90

Shares of Omada Health, Inc. (NASDAQ:OMDA) have received an average rating of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $23.60.

Several research analysts have commented on OMDA shares. Morgan Stanley dropped their price objective on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Friday, March 6th. Wells Fargo & Company assumed coverage on Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 target price on the stock. Needham & Company LLC reissued a “buy” rating and set a $28.00 price target on shares of Omada Health in a research note on Thursday, January 22nd. Barclays cut their price target on Omada Health from $22.00 to $17.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a research note on Thursday, January 22nd.

Omada Health Stock Performance

OMDA stock opened at $14.02 on Friday. The company’s fifty day moving average price is $13.89 and its 200-day moving average price is $18.49. Omada Health has a one year low of $10.28 and a one year high of $28.40. The company has a market capitalization of $826.06 million and a PE ratio of -82.47.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, March 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.12. The company had revenue of $75.85 million for the quarter.

Insider Buying and Selling at Omada Health

In other Omada Health news, President Wei-Li Shao sold 5,618 shares of Omada Health stock in a transaction on Monday, December 29th. The shares were sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the transaction, the president directly owned 69,079 shares of the company’s stock, valued at $1,114,244.27. This trade represents a 7.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $14.34, for a total transaction of $58,263.42. Following the completion of the sale, the chief executive officer owned 117,598 shares in the company, valued at approximately $1,686,355.32. This trade represents a 3.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 280,956 shares of company stock worth $4,395,050 in the last 90 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. XTX Topco Ltd bought a new stake in Omada Health during the fourth quarter worth approximately $297,000. Utah Retirement Systems bought a new stake in shares of Omada Health in the 4th quarter valued at approximately $1,237,000. VARCOV Co. purchased a new position in shares of Omada Health in the 4th quarter worth approximately $504,000. Voloridge Investment Management LLC bought a new position in shares of Omada Health during the 4th quarter valued at approximately $2,590,000. Finally, Tudor Investment Corp ET AL increased its position in shares of Omada Health by 373.7% during the 4th quarter. Tudor Investment Corp ET AL now owns 211,416 shares of the company’s stock valued at $3,336,000 after purchasing an additional 166,783 shares during the last quarter.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.